» Articles » PMID: 39926171

Fatal Empyema Thoracis Caused by

Overview
Publisher Dove Medical Press
Date 2025 Feb 10
PMID 39926171
Authors
Affiliations
Soon will be listed here.
Abstract

Nocardiosis caused by is exceptionally rare and characterized by a high mortality rate. It typically affects immunocompromised patients, resulting in severe pulmonary or disseminated infections, and is notorious for abscess formation. Empyema resulting from nocardiosis is even less common. Early clinical signs and imaging findings lack specificity, culture growth is sluggish, and the absence of an effective serological detection method can delay treatment. We report an 81-year-old patient with chronic obstructive pulmonary disease treated by long-term inhalation of high-dose salmeterol fluticasone. The initial empirical anti-infection treatment proved ineffective, resulting in rapid disease progression before the confirmation of nocardiosis with empyema through cultures of pleural fluid and sputum. Despite active treatment measures, the patient succumbed to severe pulmonary infection, sepsis, and multiple organ failure. A review of the literature, together with clinical experience, indicates that conventional empirical treatment for infection may not always be effective due to the escalating rate of drug resistance. Therefore, the primary step in the management of the infection is timely diagnosis using different methods. Furthermore, the identification of the responsible strain followed by conducting drug sensitivity tests is paramount for the successful treatment of this disease.

References
1.
LERNER P . Nocardiosis. Clin Infect Dis. 1996; 22(6):891-903; quiz 904-5. DOI: 10.1093/clinids/22.6.891. View

2.
Hamdi A, Fida M, Deml S, Abu Saleh O, Wengenack N . Retrospective Analysis of Antimicrobial Susceptibility Profiles of Species from a Tertiary Hospital and Reference Laboratory, 2011 to 2017. Antimicrob Agents Chemother. 2019; 64(3). PMC: 7038297. DOI: 10.1128/AAC.01868-19. View

3.
Lai C, Liu W, Ko W, Chen Y, Tang H, Huang Y . Antimicrobial-resistant nocardia isolates, Taiwan, 1998-2009. Clin Infect Dis. 2011; 52(6):833-5. DOI: 10.1093/cid/ciq255. View

4.
Clark N, Braun D, Pasternak A, Chenoweth C . Primary cutaneous Nocardia otitidiscaviarum infection: case report and review. Clin Infect Dis. 1995; 20(5):1266-70. DOI: 10.1093/clinids/20.5.1266. View

5.
Hemar V, Danjean M, Imbert Y, Rispal P . Retrospective analysis of nocardiosis in a general hospital from 1998 to 2017. Med Mal Infect. 2018; 48(8):516-525. DOI: 10.1016/j.medmal.2018.06.004. View